These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 1603675

  • 21. Reducing central venous catheter-related bloodstream infections in children with cancer.
    Horvath B, Norville R, Lee D, Hyde A, Gregurich M, Hockenberry M.
    Oncol Nurs Forum; 2009 Mar; 36(2):232-8. PubMed ID: 19273413
    [Abstract] [Full Text] [Related]

  • 22. Failure of antiseptic bonding to prevent central venous catheter-related infection and sepsis.
    Ciresi DL, Albrecht RM, Volkers PA, Scholten DJ.
    Am Surg; 1996 Aug; 62(8):641-6. PubMed ID: 8712561
    [Abstract] [Full Text] [Related]

  • 23. Peripherally inserted central catheters. Development of a hospital-based program.
    Kyle KS, Myers JS.
    J Intraven Nurs; 1990 Aug; 13(5):287-90. PubMed ID: 2401933
    [Abstract] [Full Text] [Related]

  • 24. Tunneled internal jugular catheters in adult patients: comparison of outcomes in hemodialysis versus infusion catheters.
    Peynircioglu B, Ozkan F, Canyigit M, Cil BE, Balkanci F.
    Acta Radiol; 2007 Jul; 48(6):613-9. PubMed ID: 17611867
    [Abstract] [Full Text] [Related]

  • 25. Low infection rate and long durability of nontunneled silastic catheters. A safe and cost-effective alternative for long-term venous access.
    Raad I, Davis S, Becker M, Hohn D, Houston D, Umphrey J, Bodey GP.
    Arch Intern Med; 1993 Aug 09; 153(15):1791-6. PubMed ID: 8392831
    [Abstract] [Full Text] [Related]

  • 26. A randomized controlled comparison of flushing protocols in home care patients with peripherally inserted central catheters.
    Lyons MG, Phalen AG.
    J Infus Nurs; 2014 Aug 09; 37(4):270-81. PubMed ID: 24983260
    [Abstract] [Full Text] [Related]

  • 27. ESPEN Guidelines on Parenteral Nutrition: central venous catheters (access, care, diagnosis and therapy of complications).
    Pittiruti M, Hamilton H, Biffi R, MacFie J, Pertkiewicz M, ESPEN.
    Clin Nutr; 2009 Aug 09; 28(4):365-77. PubMed ID: 19464090
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Methods of drawing blood samples through central venous catheters in pediatric patients undergoing bone marrow transplant: results of a national survey.
    Keller CA.
    Oncol Nurs Forum; 1994 Jun 09; 21(5):879-84. PubMed ID: 7937249
    [Abstract] [Full Text] [Related]

  • 30. Reducing central line catheter infections in bone marrow transplant patients.
    Richard-Smith A, Buh S.
    Nurs Clin North Am; 1995 Mar 09; 30(1):45-52. PubMed ID: 7885923
    [Abstract] [Full Text] [Related]

  • 31. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters.
    Fraenkel D, Rickard C, Thomas P, Faoagali J, George N, Ware R.
    Crit Care Med; 2006 Mar 09; 34(3):668-75. PubMed ID: 16505651
    [Abstract] [Full Text] [Related]

  • 32. Peripherally inserted central venous catheters in critical care patients.
    Abi-Nader JA.
    Heart Lung; 1993 Mar 09; 22(5):428-34. PubMed ID: 8226007
    [Abstract] [Full Text] [Related]

  • 33. Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients.
    Kalfon P, de Vaumas C, Samba D, Boulet E, Lefrant JY, Eyraud D, Lherm T, Santoli F, Naija W, Riou B.
    Crit Care Med; 2007 Apr 09; 35(4):1032-9. PubMed ID: 17334256
    [Abstract] [Full Text] [Related]

  • 34. An evaluation of Groshong central venous catheters on a gynecologic oncology service.
    Holloway RW, Orr JW.
    Gynecol Oncol; 1995 Feb 09; 56(2):211-7. PubMed ID: 7896188
    [Abstract] [Full Text] [Related]

  • 35. Transparent and gauze dressings and their effect on infection rates of central venous catheters: a review of past and current literature.
    Lau CE.
    J Intraven Nurs; 1996 Feb 09; 19(5):240-5. PubMed ID: 9060348
    [Abstract] [Full Text] [Related]

  • 36. Accessing implanted ports: still a source of controversy.
    Eisenberg S.
    Clin J Oncol Nurs; 2011 Jun 09; 15(3):324-6. PubMed ID: 21624868
    [Abstract] [Full Text] [Related]

  • 37. Effects of prolonged flushing interval in totally implantable venous access devices (TIVADs).
    Rasero L, Golin L, Ditta S, Di Massimo DS, Dal Molin A, Piemonte G.
    Br J Nurs; 2018 Apr 26; 27(8):S4-S10. PubMed ID: 29683741
    [Abstract] [Full Text] [Related]

  • 38. [Comparison of two different protocols on change of medication in central venous catheterization in patients with bone marrow transplantation: results of a randomized multicenter study].
    Rasero L, Degl'Innocenti M, Mocali M, Alberani F, Boschi S, Giraudi A, Arnaud MT, Zucchinali R, Paris MG, Dallara R, Thaler S, Perobelli G, Parfazi S, De Lazzer T, Peron G.
    Assist Inferm Ric; 2000 Apr 26; 19(2):112-9. PubMed ID: 11107366
    [Abstract] [Full Text] [Related]

  • 39. Developing a protocol for obtaining blood cultures from central venous catheters and peripheral sites.
    Penwarden LM, Montgomery PG.
    Clin J Oncol Nurs; 2002 Apr 26; 6(5):268-70. PubMed ID: 12240486
    [Abstract] [Full Text] [Related]

  • 40. Pilot Randomized Trial of a Three Times Weekly Heparin Flushing Intervention in Children, Adolescents, and Young Adults With Cancer With Tunneled Central Venous Catheters.
    Adlard K, Brown C, Hayward S, Barrows J, MacLean L.
    J Pediatr Hematol Oncol Nurs; 2023 Apr 26; 40(1):24-33. PubMed ID: 35611518
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.